ENCell’s investigational drug EN001 has been granted Orphan Drug Designation by the FDA for the treatment of ...
EN001, a novel therapy under development by ENCell, has been granted Orphan Drug Designation by the U.S. FDA for the treatment of Charcot-Marie-Tooth (CMT) disease. Phase 1 clinical trial confirmed ...
By State Rep. Dennis Powers House advances bill to regulate hemp-derived THC products To protect consumer health and safety, a new law seeks to regulate the sale and distribution of hemp-derived ...
A landmark study has found 69 previously unidentified genetic determinants of rare disease, including uncommon forms of ...
A landmark study has found 69 previously unidentified genetic determinants of rare disease, including uncommon forms of ...
A landmark study has found 69 previously unidentified genetic determinants of rare disease, including uncommon forms of ...
The Tennessee House of Representatives on Feb. 27 unanimously passed a resolution urging the Tennessee Department of Health ...
Rare disease patients can only benefit from research if they can be contacted about ongoing clinical trials, an expert says.
Become one of the first Fully Certified CMT-FOM Clinical Evaluators at the upcoming HNF Clinical Trial Readiness Summit in Nashvil ...
Importantly, the strongest overall genetic and experimental evidence supported the newly-discovered genetic variants for rare ...
Rare diseases collectively affect between 4% and 6% of individuals worldwide. Despite advances in genetic testing, the lack ...
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with the Siheung c ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果